3Balch CM, Soong S. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm), Intergroup melanoma surgical trial [J]. Ann Srug Oncol, 2000, 7 ( 2) : 87-97.
6McNeilage L J, Morgan J, Constable J, et al. Metastatic malignant melanoma arising in a mature ovarian cystic teratoma: a case report and literature review [J]. Gynecol Cancer, 2005, 15 (6) : 1148-1152.
7McCluggage WG, Bissonnette JP, Young RH. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms [ J]. Gynecol Pathol, 2006,25 (4) : 321-329.
8Carlson JA, Wheeler JE. Primary ovarian melanoma arising in a dermoid stage ⅢC : long-term disease-free survival with aggressive surgery and platinum therapy [ J]. Gynecol Oncol, 1993, 48(3) : 397-401.
7Jaworski RC,Boadle R,Greg J,et al.Peritoneal "melanosis"associated with a ruptured ovarian dermoid cyst:report of a case with electro-probe energy dispersive X-ray analysis[J].Int J Gynecol Pathol,2001,20(4):386-389.
8Fukushima M,Sharpe L,Okagaki T.Peritoneal melanosis secondary to a beningn dermoid cysts of the ovary:a case report with ultrastructural study[J].Int J Gynecol Pathol,1984,2 (4):403-409.
2Martin A, Weinstock MD. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival[J].Am J Obstet Gynecol, 1994,171 ( 5 ) : 1225-12301.
3Bong JL, Herd RM, Hunter JA, et al.Incisional biopsy and melanoma prognosis [J].J Am Acad Dermatol, 2002,46 ( 5 ) : 690-694.
4de Hullu ]A, Oonk MH, van der Zee AG.Modern management of vulvar cancer[J].Curr Opin Obset Gynecol, 2004, 16 ( 1 ) : 57-64.
5Rodriguez, AO.Female genital tract melanoma: the evidence is only skin deep[J].Curr Opin Obstet Gyneeol, 2005,17 ( 1 ) : 1-4.
6de Gast GC, Klumpen H J, Vyth-Dreese FA, et al.Phase I trial of combined immunotherapy with subcutanceous granulocyte macrophage colony-stimulating factor, low dose interleukin-2, and renal cell carcinoma[J].Clin Cancer Res,2000,6 ( 4 ) : 1267-1272.
7Kirkwood JM, Ibrahim JG, Sondak VK, et al.High-and Low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/$9111/C9190[J].J Clin Oneol,2000,18 ( 12 ): 2444-2458.
8Zaffar M, Scott HJ 1 Vaginal melanoma: a current review[J]. J Obstet Gynaeeol, 1998,18 ( 6 ) : 5162-5191.
9BK Ragnarsson-Olding, BR Nilsson, LR Kanter- Lewensohn, et al. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females[J]. Cancer, 1999,86 ( 7 ): 1285-1293.
10Piura B, RabinovichA, Yanai InbarI.Primary malignant melanoma of the vagina: case report and review of literature[J].Eur J Gynaecol Oncol, 2002,23 ( 3 ): 195-198.
